Chudzik, Michał, Burzyńska, Monika, Kapusta, Joanna · Nutrients · 2022 · DOI
This study tested whether a supplement called 1-MNA (a natural compound made in the liver) could help people recover better from COVID-19 fatigue. Fifty people who had recovered from COVID-19 either received the supplement or no supplement for one month. Those taking 1-MNA walked further in a walking test and reported less severe fatigue than those without it.
For post-COVID and ME/CFS patients struggling with exercise intolerance and severe fatigue, identifying potential nutritional interventions with anti-inflammatory properties could offer accessible supportive treatment options. This study directly addresses a major symptom cluster in post-acute sequelae of COVID-19 and provides preliminary evidence that may inform future larger trials and clinical management strategies.
This study does not prove that 1-MNA is effective in ME/CFS patients with other etiologies, only in post-COVID populations within a 4-week window. The mechanism by which 1-MNA improves outcomes remains inferential; the observed benefit may reflect placebo effect, natural recovery trajectory, or other unmeasured confounders. A single small trial cannot establish 1-MNA as a standard treatment recommendation without replication in larger, longer-term studies.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →